Lista de obras - Jean-Yves Blay - Dominio Público Uruguay

1363PSCREENING FOR BREAST CANCER. FEAR AND REASSURANCE: IMPACT OF THE RECENT CONTROVERSY

article by F. Eisinger et al published September 2014 in Annals of Oncology

1365PBREAST CANCER SCREENING CONTROVERSY: IMPACT ON OTHER CANCER SCREENING PROGRAMS

1390PLOW ADEQUACY BETWEEN SEVERE ADVERSE EVENTS REPORTING IN ONCOLOGY PHASE III TRIALS AND EXPECTATIONS OF THE EORTC MEMBERS

1413OZOLEDRONATE DOES NOT REDUCE THE RISK OF TREATMENT FAILURE IN OSTEOSARCOMA: RESULTS OF THE FRENCH MULTICENTRE OS2006 RANDOMISED TRIAL

article

278 Tyrosine-kinase inhibitors in very rare sarcoma subtypes

3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma

artículo científico publicado en 2017

7504 ORAL Early progression in patients with high-risk soft tissue sarcomas (STS): A phase III randomized prospective trial (EORTC/ESHO intergroup trial) of neoadjuvant chemotherapy with or without regional hyperthermia (RHT)

A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors

artículo científico publicado en 2013

A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome.

artículo científico publicado en 2017

A decade of change in the treatment of advanced soft tissue sarcoma ⬇️

artículo científico publicado el 1 de junio de 2013

A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST ⬇️

artículo científico publicado el 30 de diciembre de 2010

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

artículo científico publicado en 2013

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

artículo científico publicado en 2020

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Al

artículo científico publicado en 2014

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

artículo científico publicado en 2008

A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

artículo científico publicado en 2009

A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

artículo científico publicado en 2010

A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients

artículo científico publicado en 2002

A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours

artículo científico publicado en 2004

A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens

artículo científico publicado en 2008

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

artículo científico publicado en 2013

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

artículo científico publicado en 2015

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

artículo científico publicado en 2010

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials

article

A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group

artículo científico publicado en 2009

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

artículo científico publicado en 2015

Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?

artículo científico publicado en 2017

Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial

artículo científico publicado en 2009

Abstract 1109: The antimicrobial peptide LL37 activates plasmacytoid dendritic cells in breast cancer

Abstract 1784: Comparing genetically engineered T cells for chimeric TCR versus CD16 + Herceptin for adoptive immunotherapy against HER2 positive breast carcinomas

Abstract 2267: Long term prognostic impact of CD4 and CD8 lymphopenia and rapid recovery in a cohort of 220 patients with a 10 years follow-up

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1stline metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

Abstract 2780: Tyro3 and Axl receptors tyrosine kinase as potential therapeutic targets in leiomyosarcoma

Abstract 2940: Comprehensive biomarker program demonstrates proof of mechanism and modulation of the tumor microenvironment due to RG7155, a novel therapeutic antibody targeting tumor associated macrophages

Abstract 4447: In search of the ideal cancer screening test

Abstract 5578: IGF-1R nuclear staining in tumor cells identifies sarcoma patients with a prolonged progression free survival after IGF-1R monoclonal antibody therapy

Abstract A22: Overcoming therapeutic MAb resistance in agressive HER2-positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells

Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients

article

Abstract LB-253: A comprehensive evaluation of immune checkpoints ligands (ICPLs) in more than 1,000 cancer cell lines (CCLs) identifies specific expression patterns

Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenibvsplacebo in TKI-refractory metastatic GIST

article

Abstract PR04: Targeting tumor-asoociated macrophages with a novel anti-CSF1R antibody in cancer patients

Accomplishments in 2008 in the management of gastrointestinal stromal tumors

artículo científico publicado en 2009

Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study

artículo científico publicado en 2019

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

artículo científico publicado en 2017

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’

artículo científico publicado en 2019

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.

artículo científico publicado en 2011

Actualités 2014 : le point de vue du comité de rédaction du Bulletin du Cancer

scholarly article by Christophe Massard et al published January 2015 in Bulletin du Cancer

Added value of molecular targeted agents in oncology

artículo científico publicado en 2011

Adherence to imatinib therapy in patients with gastrointestinal stromal tumors ⬇️

artículo científico publicado el 7 de agosto de 2013

Adjuvant chemotherapy for breast cancer and targeted therapies

artículo científico publicado en 2008

Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven

scientific article published on 06 October 2009

Adjuvant chemotherapy in the treatment of sarcomas

artículo científico publicado en 2006

Adjuvant imatinib treatment in gastrointestinal stromal tumor: which risk stratification criteria and for how long? A case report

artículo científico publicado en 2016

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study

article

Adjuvant therapy in primary GIST: state-of-the-art

artículo científico publicado en 2012

Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST

artículo científico publicado en 2009

Advanced chondrosarcomas: role of chemotherapy and survival.

artículo científico publicado en 2013

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

artículo científico publicado en 2017

Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendations

artículo científico publicado en 2009

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

artículo científico publicado en 2003

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

artículo científico publicado en 2011

Advances and controversies in the management of soft tissue sarcomas

artículo científico publicado en 2017

Aggregated adverse-events outcomes in oncology phase III reports: A systematic review

artículo científico publicado en 2015

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

artículo científico publicado en 2011

American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view

artículo científico publicado en 2011

American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view

artículo científico publicado en 2012

An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours

artículo científico publicado en 2013

An unusual giant cell tumor of the thyroid: case report and review of the literature

artículo científico publicado en 2012

Analysis of genomic alterations in neuroblastoma by multiplex ligation-dependent probe amplification and array comparative genomic hybridization: a comparison of results

artículo científico publicado en 2012

Angiogenesis inhibition in non-GIST soft tissue sarcomas

artículo científico publicado en 2008

Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases

article

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series

artículo científico publicado en 2018

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)

artículo científico publicado en 2017

Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting.

artículo científico publicado en 2015

Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99 m skeletal angioscintigraphy

article

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome

artículo científico publicado en 2006

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas

artículo científico publicado en 2013

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

artículo científico publicado en 2003

Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.

artículo científico publicado en 2009

Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)

artículo científico publicado en 2018

Breast cancer screening controversy: too much or not enough?

artículo científico publicado en 2015

Breast cancer screening in women aged 50-74 years: is there room for improvement?

artículo científico publicado en 2011

Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.

artículo científico publicado en 2013

Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypes.

artículo científico publicado en 2004

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco

artículo científico publicado en 2013

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2006

CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues

artículo científico publicado en 2011

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.

artículo científico publicado en 2004

CD4 lymphopenia to identify end-of-life metastatic cancer patients

artículo científico publicado en 2012

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

artículo científico publicado en 2005

CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways

artículo científico publicado en 2006

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

artículo científico publicado en 2015

Cancer screening in France: subjects' and physicians' attitudes

artículo científico publicado en 2007

Cancer screening in France: third edition of the EDIFICE survey

artículo científico publicado en 2015

Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors.

artículo científico publicado en 2009

Challenges in the implementation of trastuzumab biosimilars: an expert panel's recommendations.

artículo científico

Challenges in the value assessment, pricing and funding of targeted combination therapies in oncology

artículo científico publicado en 2019

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006

scientific article published on 24 December 2010

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).

artículo científico publicado en 2011

Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study

artículo científico publicado en 2012

Circulating tumor DNA genomics reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant metastatic non-small cell lung cancer patients

artículo científico publicado en 2020

Circulating tumor cells and biomarker modulation with olaratumab monotherapy followed by olaratumab plus doxorubicin: phase 1b study in soft tissue sarcoma patients

scientific article published on 11 November 2020

Classification of current anticancer immunotherapies

artículo científico publicado en 2014

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

artículo científico publicado en 2011

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

artículo científico publicado en 2009

Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

artículo científico publicado en 2001

Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative ⬇️

artículo científico publicado en 2014

Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

artículo científico publicado en 2012

Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role

artículo científico publicado en 2004

Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication

artículo científico publicado en 2008

Combination treatment of rituximab and imatinib mesylate for simultaneous relapse of MALT lymphoma and a gastrointestinal stromal tumor

artículo científico publicado en 2004

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.

artículo científico publicado en 2011

Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure

artículo científico publicado en 2012

Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment

article

Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene

article

Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).

artículo científico publicado en 2008

Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas

artículo científico publicado en 2004

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

artículo científico publicado en 2005

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

artículo científico publicado en 2015

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG).

artículo científico

Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group

artículo científico publicado en 2013

Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial

artículo científico publicado en 2016

Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study

artículo científico

Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors

artículo científico publicado en 2016

Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone

artículo científico publicado en 2016

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

artículo científico publicado en 2012

Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases

artículo científico publicado en 2007

DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours

artículo científico publicado en 2010

Decision making process in oncology practice: Is the information available and what should it consist of?

Deep learning-based classification of mesothelioma improves prediction of patient outcome

artículo científico publicado en 2019

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

artículo científico publicado en 2004

Dendritic cells and gliomas: a hope in immunotherapy?

artículo científico publicado en 2006

Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model

artículo científico publicado en 2005

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

artículo científico publicado en 2012

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

artículo científico publicado en 2010

Depression assessment by oncologists and palliative care physicians

artículo científico publicado en 2012

Desmoplastic small round cell tumor: current management and recent findings

artículo científico publicado en 2012

Desmoplastic small round cell tumors with EWS-WT1 fusion transcript in children and young adults

artículo científico publicado en 2011

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

article

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

scientific article published on 12 February 2020

Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.

artículo científico publicado en 2013

Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients

artículo científico publicado en 2015

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

artículo científico publicado en 2010

Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response

artículo científico publicado en 2015

Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate

artículo científico publicado en 2008

Do our current clinical trial designs help to guide clinical practice?

artículo científico

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

artículo científico publicado en 2006

Dotlike or Golgi-like KIT and PDGFRA Staining in GISTs

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

artículo científico publicado en 2017

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

artículo científico publicado en 2014

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tiss

artículo científico publicado en 2020

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

artículo científico publicado en 2014

Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling

artículo científico publicado en 2014

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.

artículo científico

ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

artículo científico publicado en 2011

ET-743: a novel agent with activity in soft tissue sarcomas

artículo científico publicado en 2005

ET-743: a novel agent with activity in soft-tissue sarcomas

artículo científico publicado en 2006

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol

artículo científico publicado en 2019

Early Variations of Circulating Interleukin-6 and Interleukin-10 Levels During Thoracic Radiotherapy Are Predictive for Radiation Pneumonitis

Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells

artículo científico publicado en 2011

Economic Impact of Centralized Histological Reviews in Patients with Sarcoma, Gist, and Desmoid Tumors

scientific article published on 26 October 2014

Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database

artículo científico publicado en 2010

Effect of cigarette smoking on imatinib in patients in the soft tissue and bone sarcoma group of the EORTC.

artículo científico publicado en 2008

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2000

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

artículo científico publicado en 2012

Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.

artículo científico publicado en 2012

Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors

artículo científico publicado en 2010

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

artículo científico publicado en 2012

Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma

artículo científico publicado en 2013

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

artículo científico publicado en 2011

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

artículo científico publicado en 2007

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution

artículo científico publicado en 2010

Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

artículo científico publicado en 2015

Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma

artículo científico publicado en 2015

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years ⬇️

artículo científico publicado el 1 de agosto de 1997

Emerging drugs for the treatment of soft tissue sarcomas

artículo científico publicado en 2007

Equal access to innovative therapies and precision cancer care

artículo científico publicado en 2016

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

artículo científico publicado en 2016

Erratum

Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study

scholarly article by Annemiek M. van Maldegem et al published 22 September 2014 in Pediatric Blood Cancer

European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas

artículo científico publicado en 2016

Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses

artículo científico publicado en 2003

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study

artículo científico publicado en 2020

Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients

artículo científico publicado en 2012

Evolving role of regorafenib for the treatment of advanced cancers

artículo científico publicado en 2020

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2007

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

artículo científico publicado en 2017

Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients

artículo científico publicado en 2007

Fifteen important questions for oncology to be addressed from 2015

scientific article published on 01 June 2015

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

artículo científico publicado en 2020

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis

artículo científico publicado en 2015

First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study

artículo científico publicado en 2012

Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer

artículo científico publicado en 2010

Foreword

scientific article published on 08 April 2020

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs

scientific article published on 28 September 2011

Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generation

artículo científico publicado en 1990

Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors

artículo científico publicado en 1989

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

artículo científico publicado en 2013

Gastro-intestinal stromal tumors: news and comments

artículo científico publicado en 2003

Gastrointestinal stromal tumors (GIST).

artículo científico publicado en 2006

Gastrointestinal stromal tumors (GIST): a rare entity, a tumor model for personalized therapy, and yet ten different molecular subtypes

artículo científico publicado el 1 de mayo de 2012

Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I.

artículo científico publicado en 2015

Gastrointestinal stromal tumors of the stomach and duodenum

artículo científico

Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up

artículo científico publicado en 2007

Gastrointestinal stromal tumors: biology and treatment

artículo científico publicado en 2003

Gastrointestinal stromal tumours in pediatrics: a summary of the literature on this orphan disease

artículo científico publicado en 2011

Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.

artículo científico publicado en 2009

Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment

artículo científico publicado en 2006

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.

artículo científico publicado en 2002

Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival

artículo científico publicado en 2015

Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples

artículo científico publicado en 2013

Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2

artículo científico publicado en 1988

Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004.

artículo científico publicado en 2005

Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

artículo científico publicado en 2013

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol

artículo científico publicado en 2017

Giant cell tumors of bone

article published in 2015

Giant cell tumour of bone in the denosumab era.

artículo científico publicado en 2017

Giant-cell tumor of bone, anti-RANKL therapy

scientific article published on 05 September 2012

Going further in the knowledge of Yondelis®; what's new in clinical trials?

artículo científico publicado en 2014

Going further in the knowledge of Yondelis®; what's new in daily clinical practice?

artículo científico publicado en 2014

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

artículo científico publicado en 2012

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

artículo científico publicado en 2014

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization f

artículo científico publicado en 2015

Hemorrhage due to radiation-induced sarcoma of the mandible: Treatment with percutaneous cryotherapy

artículo científico publicado en 2015

Hepatic angiosarcoma in a patient with essential thrombocythaemia and Budd-Chiari syndrome

artículo científico publicado en 1995

High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

artículo científico publicado en 2010

High frequency ofMYCgene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01

artículo científico publicado en 2012

High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial

artículo científico publicado en 2011

High-dose chemotherapy in soft tissue sarcomas of adults

artículo científico publicado en 2001

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults

artículo científico publicado en 2000

High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin’s lymphomas: a single center experience on 18 patients

scientific article published on 01 January 1998

High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Soc

artículo científico publicado en 1999

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

artículo científico publicado en 2017

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4(+) T cells by plasmacytoid dendritic cells

artículo científico publicado en 2013

ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells

artículo científico publicado en 2012

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

artículo científico publicado en 2010

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

artículo científico publicado en 2001

Imatinib and solid tumours

artículo científico publicado en 2008

Imatinib as a possible cause of severe rhabdomyolysis

artículo científico publicado en 2008

Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

artículo científico publicado en 2010

Imatinib in gastrointestinal stromal tumor: does treatment duration matter?

artículo científico publicado en 2009

Imatinib in patients with metastatic gastrointestinal stromal tumours relapsing after hepatic transplantation

artículo científico publicado en 2004

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

artículo científico publicado en 2008

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa

artículo científico publicado en 2003

Imatinib mesylate for the treatment of gastrointestinal stromal tumor

scientific article published on May 2010

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors

artículo científico publicado en 2012

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

artículo científico publicado en 2013

Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology

artículo científico publicado en 2014

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial

artículo científico publicado en 2018

Impact of awareness of cancer among acquaintances on cancer screening attendance

artículo científico publicado en 2011

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line ch

artículo científico publicado en 2016

Impact of general practitioners' sex and age on systematic recommendation for cancer screening.

artículo científico publicado en 2011

Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study

artículo científico publicado en 2013

Impact of organised programs on colorectal cancer screening.

artículo científico publicado en 2008

Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

article

Improved survival using specialized multidisciplinary board in sarcoma patients

artículo científico publicado en 2017

Improving treatment results with reference centres for rare cancers: where do we stand?

artículo científico publicado en 2017

Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour

artículo científico publicado en 2006

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

artículo científico publicado en 2011

Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.

artículo científico publicado en 2012

Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region

artículo científico publicado en 2010

Increasing coverage rates for mammographic screening in France in older women--16 years of follow-up

artículo científico publicado en 2011

Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

artículo científico publicado en 2012

Influenza vaccination in patients with haematologic malignancies: analysis of practices in 200 patients in a single center

artículo científico publicado en 2010

Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model ⬇️

artículo científico publicado el 27 de junio de 2012

Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment.

artículo científico publicado en 2012

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas

artículo científico publicado en 2012

Intensity of recent years in the investigation of soft tissue sarcoma

artículo científico publicado en 2017

Interleukin-6 and epithelial tumours: new convincing arguments in favour of the use of IL-6 targeted therapies

artículo científico publicado en 2008

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

artículo científico publicado en 2004

International expert opinion on patient-tailored management of soft tissue sarcomas

artículo científico publicado en 2013

International study on low-grade primary central nervous system lymphoma

artículo científico publicado en 2006

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

artículo científico publicado en 2015

Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma ⬇️

artículo científico publicado el 1 de mayo de 1992

Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?

scientific article published on July 2009

KIT and KIT: from biology to clinical use

artículo científico publicado en 2012

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome

artículo científico publicado en 2015

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

artículo científico publicado en 2006

KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors

artículo científico publicado en 2008

Key Issues in the Clinical Management of Gastrointestinal Stromal Tumors: An Expert Discussion

artículo científico publicado en 2015

La liste en sus de la tarification à l’activité pour les agents anticancéreux : genèse et évolution

scholarly article by Gilles Freyer et al published April 2016 in Bulletin du Cancer

Le futur des thérapeutiques ciblées en oncologie : trouver les cibles, traiter tôt et au long cours

Les sarcomes des tissus mous : bonnes pratiques médicales pour une prise en charge optimale

scientific article published on 01 December 2005

Letter: Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era

scientific article published on 29 January 2020

Local Production of Interleukin 6 by Renal Adenocarcinoma In Vivo

article

Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor

scientific article published on 01 August 2019

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)

scientific article published on 20 May 2020

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor

artículo científico publicado en 2019

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

artículo científico publicado en 2009

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

artículo científico publicado en 2013

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

artículo científico publicado en 2015

Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-up

Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathways

artículo científico publicado en 2020

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial

artículo científico publicado en 2013

Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibody

artículo científico publicado en 2009

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

artículo científico publicado en 2009

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

artículo científico publicado en 2012

Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma

artículo científico publicado en 2005

L’année 2015 à travers le regard du comité de rédaction du Bulletin du cancer

scholarly article by Nicolas Magné et al published January 2016 in Bulletin du Cancer

MDM4 amplification in a case of de-differentiated liposarcoma and in-silico data supporting an oncogenic event alternative to MDM2 amplification in a subset of cases.

artículo científico publicado en 2017

MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer

scientific article published on 01 June 2020

Mammography utilization in women aged 40–49 years

artículo científico publicado en 2011

Management of Gastrointestinal Stromal Tumour: Current Practices and Visions for the Future

artículo científico

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

artículo científico publicado en 2016

Management of gastrointestinal stromal tumors in the imatinib era: selected case studies

artículo científico publicado en 2006

Management of gastrointestinal stromal tumours of limited size: proposals from a French panel of physicians

artículo científico publicado en 2011

Management of imatinib-associated skin rash in a patient with metastatic gastrointestinal stromal tumor: a case report ⬇️

artículo científico publicado el 4 de diciembre de 2012

Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma

artículo científico publicado en 2009

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial

artículo científico publicado en 2014

Medulloblastoma in adults: survival and prognostic factors

artículo científico publicado en 1993

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

artículo científico publicado en 2011

Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response

artículo científico publicado en 2010

Molecular biology of sarcoma and therapeutic choices

artículo científico publicado en 2015

Molecular characterisation of gastrointestinal stromal tumours in a South African population

artículo científico publicado en 2012

Molecular response prediction in gastrointestinal stromal tumors

artículo científico publicado en 2010

Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Res

artículo científico publicado en 2010

Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organization

artículo científico publicado en 2012

Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring.

artículo científico publicado en 1993

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

artículo científico publicado en 2016

Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients

artículo científico publicado en 2009

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

artículo científico publicado en 2010

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

artículo científico publicado en 2008

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

artículo científico publicado en 2011

New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC – Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas

artículo científico publicado en 2022

New fronts in the adjuvant treatment of GIST.

artículo científico publicado en 2013

New paradigms in gastrointestinal stromal tumour management.

artículo científico publicado en 2009

News of the year 2005 in sarcomas

artículo científico publicado en 2006

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

artículo científico publicado en 2018

Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial

artículo científico publicado en 2015

Nilotinib versus imatinib for GIST - Authors' reply

artículo científico publicado en 2015

Nilotinib: a novel, selective tyrosine kinase inhibitor

scientific article published on April 2011

Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib

artículo científico publicado en 2008

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

artículo científico publicado en 2004

Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).

artículo científico publicado en 2015

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2015

Optimizing current drugs

artículo científico publicado en 2005

Optimizing treatment outcomes with regorafenib: personalized dosing and other strategies to support patient care

artículo científico publicado en 2014

Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression

artículo científico publicado en 2013

Organized colorectal cancer screening programmes

artículo científico publicado en 2011

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

artículo científico publicado en 2018

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.

artículo científico publicado en 2005

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

artículo científico publicado en 2013

Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

artículo científico publicado en 2012

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.

artículo científico publicado en 2016

Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment

artículo científico publicado en 2020

Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells

artículo científico publicado en 2013

P-700 Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis in patients with non-small cell lung cancer: A prospective study

PTPN11 mutations in canine and human disseminated histiocytic sarcoma

artículo científico publicado en 2020

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

artículo científico publicado en 2015

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

artículo científico publicado en 2008

Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

artículo científico publicado en 2020

Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome

scientific article published on 19 December 2012

Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients.

artículo científico publicado en 1993

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

artículo científico publicado en 2017

Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib

artículo científico publicado en 2011

Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG

artículo científico publicado en 2020

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2012

Pazopanib for metastatic soft-tissue sarcoma – Authors' reply

artículo científico publicado en 2012

Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience

artículo científico publicado en 2014

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

artículo científico publicado en 2019

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

artículo científico publicado en 2016

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

artículo científico publicado en 2009

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (

article

Personalised medicine in oncology: questions for the next 20 years

artículo científico publicado en 2012

Personalized medicine in oncology: where have we come from and where are we going?

artículo científico publicado en 2013

Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors

artículo científico publicado en 2010

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

artículo científico publicado en 2020

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

scientific article published on 01 October 2006

Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib

scientific article published on 12 August 2009

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sar

artículo científico publicado en 2006

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers.

artículo científico publicado en 2009

Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma

artículo científico publicado en 2008

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages

scientific article published on 01 August 2019

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

artículo científico publicado en 2012

Phase I study of interleukin-6 in children with solid tumours in relapse

artículo científico publicado en 1997

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

artículo científico publicado en 2011

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

artículo científico publicado en 2005

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients

artículo científico publicado en 2004

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).

artículo científico publicado en 2010

Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas

artículo científico publicado en 2011

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

artículo científico publicado en 2008

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Stud

article

Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.

artículo científico publicado en 2012

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

artículo científico publicado en 2009

Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte

artículo científico publicado en 2007

Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3(+) regulatory T cells and are associated with poor prognosis in breast cancer patients.

artículo científico publicado en 2013

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

artículo científico publicado en 2012

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG

scientific article published on 05 February 2019

Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Tria

article

Prediction of desmoid tumor progression using miRNA expression profiling

artículo científico publicado en 2015

Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study

artículo científico publicado en 2011

Pregnancy in Women with Metastatic Sarcomas

scientific article published on 19 September 2020

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

artículo científico publicado en 2017

Pressure-suit combined with pelvic stop-flow: a feasibility study in a bovine model

artículo científico publicado en 2006

Pretreatment serum CRP and response to interleukin 2.

artículo científico publicado en 1994

Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

artículo científico publicado en 2011

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group

artículo científico publicado en 2005

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

artículo científico publicado en 2008

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group

artículo científico publicado en 2013

Primary cerebral lymphomas: unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses. The FNCLCC. French Fédération Nationale des Centres de Lutte contre le Cancer

artículo científico publicado en 2000

Primary cutaneous and subcutaneous Ewing sarcoma

artículo científico publicado en 2015

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report

artículo científico publicado en 2007

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report

artículo científico publicado en 2013

Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group

artículo científico publicado en 2014

Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control

artículo científico publicado en 2008

Prognosis and predictive value of KIT exon 11 deletion in GISTs

artículo científico publicado en 2009

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

scientific article published on 11 October 2018

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

article by Stefan Sleijfer et al published January 2010 in European Journal of Cancer

Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting

artículo científico publicado en 2014

Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 6

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation

artículo científico publicado en 2011

Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study

artículo científico publicado en 2017

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

artículo científico publicado en 2003

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

artículo científico publicado en 2003

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer

artículo científico publicado en 2011

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study

artículo científico publicado en 2019

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

artículo científico publicado en 2004

Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group

scientific article published on 29 September 2020

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

artículo científico publicado en 2021

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group

artículo científico publicado en 2007

Prostate cancer screening: contrasting trends

artículo científico publicado en 2015

Proteasome inhibition: a new approach for the treatment of malignancies.

artículo científico publicado en 2005

Pulmonary artery sarcoma during postpartum: CT findings

artículo científico publicado en 2006

Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study

artículo científico publicado en 2012

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

scientific article published on 01 April 2020

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

artículo científico publicado en 2011

Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib

artículo científico publicado en 2010

REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis

artículo científico publicado en 2017

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2001

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

artículo científico

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G

article

Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis

article

Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients

artículo científico publicado en 2002

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper.

artículo científico publicado en 2014

Rationale and delineation of a composite index of relative antitumoural efficacy (In-RATE)

Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas

artículo científico publicado en 2007

Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma

artículo científico publicado en 2020

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

artículo científico publicado en 2012

Recommandations pour la prise en charge des tumeurs stromales gastro-intestinales

artículo científico publicado en 2006

Recommendations for diagnostic and therapeutic management of soft tissue sarcoma

artículo científico publicado en 2009

Recommendations for the management of GIST patients

artículo científico publicado en 2005

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

artículo científico publicado en 2009

Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting

artículo científico publicado en 2016

Relevance of intraocular involvement in the management of primary central nervous system lymphomas

artículo científico publicado en 2002

Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes

artículo científico publicado en 1999

Reply to Y. Nishida et al

Research controversies in management of oral mucositis.

artículo científico publicado en 2000

Response to chemotherapy is not related to chromosome instability in synovial sarcoma

artículo científico publicado en 2014

Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study

scientific article published on 19 July 2019

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998).

artículo científico publicado en 2013

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer.

artículo científico publicado en 2004

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy

artículo científico publicado en 2013

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

artículo científico publicado en 2014

Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

artículo científico publicado en 2014

Risk Model Predictive of Severe Anemia Requiring RBC Transfusion After Chemotherapy in Pediatric Solid Tumor Patients

article

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

artículo científico publicado en 2019

Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma ⬇️

artículo científico publicado el 29 de julio de 1997

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

artículo científico publicado en 2015

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

artículo científico

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

artículo científico publicado en 2016

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

artículo científico publicado en 2012

Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years

scientific article published on 15 April 2019

Sarcomas with spindle cell morphology

artículo científico publicado en 2009

Screening for prostate cancer: growth without control.

artículo científico publicado en 2011

Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma.

artículo científico publicado en 2004

Serum concentrations of cytokines in patients with Hodgkin's disease

artículo científico publicado en 1994

Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors

artículo científico publicado en 2012

Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival.

artículo científico publicado en 2009

Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Report of a Bilateral Case in a Teenager Associated with SMARCA4 Germline Mutation

artículo científico publicado en 2015

Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis

artículo científico publicado en 2009

Social stratification, risk factor prevalence and cancer screening attendance.

artículo científico publicado en 2015

Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up

artículo científico publicado en 2009

Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?

artículo científico publicado en 2011

Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis.

artículo científico publicado en 2012

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2012

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)

artículo científico publicado en 2015

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2013

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

scientific article published on 12 July 2020

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group

artículo científico publicado en 2013

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

artículo científico publicado en 2015

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.

artículo científico publicado en 1994

Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.

artículo científico publicado en 2003

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study

artículo científico publicado en 2014

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

scientific article published on 01 July 2019

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

artículo científico publicado en 2017

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)

artículo científico publicado en 2017

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network

scientific article published on 19 September 2019

Targeted cancer therapies.

artículo científico publicado en 2005

Targeted imaging of α(v)β(3) expressing sarcoma tumor cells in vivo in pre-operative setting using near infrared: a potential tool to reduce incomplete surgical resection.

artículo científico publicado en 2014

Targeted polytherapy in small cell sarcoma and its association with doxorubicin

artículo científico publicado en 2014

Targeted therapy of sarcomas

artículo científico publicado en 2008

Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002

artículo científico publicado en 2002

Targeted treatment of rare connective tissue tumors and sarcomas

artículo científico publicado en 2010

Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas.

artículo científico publicado en 2004

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

artículo científico publicado en 2014

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointesti

artículo científico publicado en 2017

Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region

artículo científico publicado en 2013

Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.

artículo científico publicado en 2010

The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours

artículo científico publicado en 2015

The Genomic Grade Index predicts post-operative clinical outcome in patients with soft tissue sarcoma

artículo científico publicado en 2017

The clinician's perspective on sarcoma pathology reporting: impact on treatment decisions?

artículo científico publicado en 2014

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group

artículo científico publicado en 2018

The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments

scientific article published on 29 April 2020

The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists

artículo científico publicado en 2010

The evolution of a revolutionary class: extending benefits of tyrosine kinase inhibitors--introduction

artículo científico publicado en 2011

The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors

artículo científico publicado en 2014

The host-tumor immune conflict: from immunosuppression to resistance and destruction

artículo científico publicado en 1997

The off-label use of targeted therapies in sarcomas: the OUTC'S program

artículo científico publicado en 2014

The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members

artículo científico publicado en 2015

The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary report

article

The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor

artículo científico publicado en 2010

The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines

artículo científico publicado en 2015

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value

artículo científico publicado en 2015

The value of research collaborations and consortia in rare cancers

artículo científico publicado en 2016

Therapeutic pipeline for soft-tissue sarcoma

artículo científico publicado en 2011

Thérapeutiques antiangiogéniques des tumeurs solides

artículo científico publicado en 2007

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomi

artículo científico publicado en 2015

To answer rare cancer issues. Geographical analysis of EMS sarcoma cohort in the Rhône-Alpes region

artículo científico publicado en 2014

Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma

artículo científico publicado en 2020

Tolerance Evaluation of L -asparaginase loaded in red blood cells

artículo científico publicado en 1996

Towards global consensus in the treatment of gastrointestinal stromal tumor

artículo científico publicado en 2010

Trabectedin and its potential in the treatment of soft tissue sarcoma.

artículo científico publicado en 2008

Trabectedin for the management of soft-tissue sarcoma

artículo científico publicado en 2009

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

artículo científico publicado en 2015

Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group

artículo científico publicado en 2015

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials

scientific article published on 10 September 2013

Trabectedin’s contribution to the treatment of sarcomas ⬇️

artículo científico publicado el 1 de junio de 2013

Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool

artículo científico publicado en 2014

Treating metastatic sarcomas locally: a paradoxe, a rationale, an evidence?

artículo científico publicado en 2015

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)

artículo científico publicado en 2017

Trends in survival for patients with metastatic soft-tissue sarcoma

artículo científico publicado en 2010

Tumeur stromale colique asymptomatique révélée par un sarcome de Kaposi classique chez une malade VIH négative

artículo científico publicado en 2004

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.

artículo científico publicado en 2014

Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment

artículo científico publicado en 2013

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

scientific article published on 12 April 2020

Updating progress in sarcoma therapy with mTOR inhibitors

artículo científico publicado en 2010

Uptake of breast cancer screening in women aged over 75 years: a controversy to come?

artículo científico publicado en 2011

Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement

artículo científico publicado en 2011

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial

artículo científico publicado en 2018

Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours.

artículo científico publicado en 2018

Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.

artículo científico publicado en 2014

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

artículo científico publicado en 2019

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

artículo científico publicado en 2010

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

artículo científico publicado en 2011

Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.

artículo científico publicado en 2017

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

artículo científico publicado en 2015

Workshop report on the 2nd Joint ENCCA/EuroSARC European bone sarcoma network meeting: integration of clinical trials with tumour biology

artículo científico publicado en 2014

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

artículo científico publicado en 2016

[Decision making process in oncology: rationale and delineation of a composite index of relative antitumoral efficacy (In-RATE)]

artículo científico publicado en 2008

[Edifice program: analysis of screening exam practices for cancer in France]

artículo científico publicado en 2008

[French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak]

scientific article published on 01 April 2020

[Major advances in Oncology in 2013: the editorial board of the Bulletin du Cancer point of view]

artículo científico publicado en 2014

[Neoadjuvant chemotherapy in sarcoma]

artículo científico publicado en 2006

[Prognostic factors for febrile neutropenia].

artículo científico publicado en 2006

miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas ⬇️

artículo científico publicado el 22 de febrero de 2011

Quimioterapia de sarcomas: optimizacion de farmacos existentes y nuevas moleculas

artículo científico publicado en 2005

Lista de obras de Jean-Yves Blay

1363PSCREENING FOR BREAST CANCER. FEAR AND REASSURANCE: IMPACT OF THE RECENT CONTROVERSY

1365PBREAST CANCER SCREENING CONTROVERSY: IMPACT ON OTHER CANCER SCREENING PROGRAMS

1390PLOW ADEQUACY BETWEEN SEVERE ADVERSE EVENTS REPORTING IN ONCOLOGY PHASE III TRIALS AND EXPECTATIONS OF THE EORTC MEMBERS

1413OZOLEDRONATE DOES NOT REDUCE THE RISK OF TREATMENT FAILURE IN OSTEOSARCOMA: RESULTS OF THE FRENCH MULTICENTRE OS2006 RANDOMISED TRIAL

278 Tyrosine-kinase inhibitors in very rare sarcoma subtypes

3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma

7504 ORAL Early progression in patients with high-risk soft tissue sarcomas (STS): A phase III randomized prospective trial (EORTC/ESHO intergroup trial) of neoadjuvant chemotherapy with or without regional hyperthermia (RHT)

A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors

A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome.

A decade of change in the treatment of advanced soft tissue sarcoma ⬇️

A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST ⬇️

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Al

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients

A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours

A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials

A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?

Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial

Abstract 1109: The antimicrobial peptide LL37 activates plasmacytoid dendritic cells in breast cancer

Abstract 1784: Comparing genetically engineered T cells for chimeric TCR versus CD16 + Herceptin for adoptive immunotherapy against HER2 positive breast carcinomas

Abstract 2267: Long term prognostic impact of CD4 and CD8 lymphopenia and rapid recovery in a cohort of 220 patients with a 10 years follow-up

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1stline metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

Abstract 2780: Tyro3 and Axl receptors tyrosine kinase as potential therapeutic targets in leiomyosarcoma

Abstract 2940: Comprehensive biomarker program demonstrates proof of mechanism and modulation of the tumor microenvironment due to RG7155, a novel therapeutic antibody targeting tumor associated macrophages

Abstract 4447: In search of the ideal cancer screening test

Abstract 5578: IGF-1R nuclear staining in tumor cells identifies sarcoma patients with a prolonged progression free survival after IGF-1R monoclonal antibody therapy

Abstract A22: Overcoming therapeutic MAb resistance in agressive HER2-positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells

Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients

Abstract LB-253: A comprehensive evaluation of immune checkpoints ligands (ICPLs) in more than 1,000 cancer cell lines (CCLs) identifies specific expression patterns

Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenibvsplacebo in TKI-refractory metastatic GIST

Abstract PR04: Targeting tumor-asoociated macrophages with a novel anti-CSF1R antibody in cancer patients

Accomplishments in 2008 in the management of gastrointestinal stromal tumors

Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.

Actualités 2014 : le point de vue du comité de rédaction du Bulletin du Cancer

Added value of molecular targeted agents in oncology

Adherence to imatinib therapy in patients with gastrointestinal stromal tumors ⬇️

Adjuvant chemotherapy for breast cancer and targeted therapies

Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven

Adjuvant chemotherapy in the treatment of sarcomas

Adjuvant imatinib treatment in gastrointestinal stromal tumor: which risk stratification criteria and for how long? A case report

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study

Adjuvant therapy in primary GIST: state-of-the-art

Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST

Advanced chondrosarcomas: role of chemotherapy and survival.

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendations

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

Advances and controversies in the management of soft tissue sarcomas

Aggregated adverse-events outcomes in oncology phase III reports: A systematic review

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view

American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view

An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours

An unusual giant cell tumor of the thyroid: case report and review of the literature

Analysis of genomic alterations in neuroblastoma by multiplex ligation-dependent probe amplification and array comparative genomic hybridization: a comparison of results

Angiogenesis inhibition in non-GIST soft tissue sarcomas

Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)

Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting.

Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99 m skeletal angioscintigraphy

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.